Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_assertion type Assertion NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_head.
- NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_assertion description "[Novel ALK fusions are being identified in various tumors in addition to IMT, and thus a reassessment of other ALK-negative cancers may be required in the forthcoming era of ALK-inhibitor therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_provenance.
- NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_assertion evidence source_evidence_literature NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_provenance.
- NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_assertion SIO_000772 21430068 NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_provenance.
- NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_assertion wasDerivedFrom befree-2016 NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_provenance.
- NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_assertion wasGeneratedBy ECO_0000203 NP881771.RAQSUzSb_9K7LiSP0SxMhvbW3Ky-L5GOpKCohnNldVDCY130_provenance.